Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Luis‐Emilio García‐Pérez"'
Autor:
Kristina S. Boye, Dara Stein, Louis S. Matza, Jessica Jordan, Ren Yu, Kirsi Norrbacka, Syed Wasi Hassan, Luis-Emilio García-Pérez
Publikováno v:
Drugs in R&D, Vol 19, Iss 2, Pp 213-225 (2019)
Abstract Introduction Patients with type 2 diabetes mellitus (T2DM) who fail to meet glycaemic control are at increased risk of diabetes complications. For patients who cannot maintain glycaemic control with oral medication, one recommended option is
Externí odkaz:
https://doaj.org/article/99e88e125fc044d781b3c197648faf13
Autor:
Bruno Guerci, Francesco Giorgino, Hélène Sapin, Kristina Boye, Jérémie Lebrec, Marco Orsini Federici, Elke Heitmann, Anne Dib, Martin Füchtenbusch, Luis‐Emilio García‐Pérez
Publikováno v:
Diabetes, Obesity and Metabolism. 24:2373-2382
Autor:
Francesco Giorgino, Bruno Guerci, Luis-Emilio García-Pérez, Martin Füchtenbusch, Jeremie Lebrec, Marco Orsini Federici, Anne Dib, Elke Heitmann, Maria Yu, Kristina Boye
Publikováno v:
Diabetologie und Stoffwechsel.
Autor:
Ian Neeland, Kenneth Cusi, Adam Stefanski, Palash Sharma, Elisa Gomez Valderas, Ryan Griffin, Luis-Emilio García-Pérez, Donna Mojdami
Publikováno v:
Endocrine Practice. 29:S35-S36
Publikováno v:
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Universidad Europea (UEM)
Aim: To investigate the association between treatment with dulaglutide and glycaemic variability (GV) in adult patients with type 2 diabetes mellitus (T2D). Materials and methods: Post hoc analyses of six randomized, phase 3 studies were conducted to
Autor:
Bruno, Guerci, Francesco, Giorgino, Hélène, Sapin, Kristina, Boye, Jérémie, Lebrec, Marco Orsini, Federici, Elke, Heitmann, Anne, Dib, Martin, Füchtenbusch, Luis-Emilio, García-Pérez
Publikováno v:
Diabetes, obesitymetabolism. 24(12)
The primary objective of the TROPHIES observational study is to estimate the duration of treatment on dulaglutide or liraglutide without a significant treatment change by 24 months in patients with type 2 diabetes (T2D) initiating their first injecta
Autor:
null Bruno Guerci, null Francesco Giorgino, null Hélène Sapin, null Kristina Boye, null Jérémie Lebrec, null Marco Orsini Federici, null Elke Heitmann, null Anne Dib, null Martin Füchtenbusch, null Luis‐Emilio García‐Pérez
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7074bb685d14026d33ff6aae63124b46
https://doi.org/10.1111/dom.14823/v2/response1
https://doi.org/10.1111/dom.14823/v2/response1
Autor:
Bruno Guerci, Francesco Giorgino, Luis-Emilio García-Pérez, Kristina Boye, Kirsi Norrbacka, Helene Sapin, Elke Heitmann, Jeremie Lebrec, Anne Dib, Marco Orsini Federici, Martin Füchtenbusch
Publikováno v:
Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.de.
Autor:
Louis S. Matza, Kristina S. Boye, Katie D. Stewart, Karin S. Coyne, Paula K. Wullenweber, Katelyn N. Cutts, Jessica B. Jordan, Qianqian Wang, Maria Yu, Brooke M. Currie, Karen G. Malley, K. Jack Ishak, Ryan T. Hietpas, Luis‐Emilio García‐Pérez
Publikováno v:
Diabetes, Obesity and Metabolism. 22